Establishes maximum fair prices for certain prescription drugs and prohibits manufacturers from withdrawing drugs from sale without notice.

The bill establishes maximum fair prices for prescription drugs subject to the Medicare Drug Price Negotiation Program. It prohibits manufacturers from accepting payments exceeding these prices for drugs sold in Minnesota. Manufacturers must notify the commissioner of health 180 days in advance if they plan to withdraw a drug from sale or distribution. Violators face civil penalties. Health plans and pharmacy benefit managers must provide financial information to the Prescription Drug Affordability Board. The bill takes effect January 1, 2027.

Establishes maximum fair prices for certain prescription drugs and prohibits manufacturers from withdrawing drugs from sale without notice.

The bill establishes maximum fair prices for prescription drugs subject to the Medicare Drug Price Negotiation Program. It prohibits manufacturers from accepting payments exceeding these prices for drugs sold in Minnesota. Manufacturers must notify the commissioner of health 180 days in advance if they plan to withdraw a drug from sale or distribution. Violators face civil penalties. Health plans and pharmacy benefit managers must provide financial information to the Prescription Drug Affordability Board. The bill takes effect January 1, 2027.